Advertisement

Topics

AI firm Atomwise secures $45mm Series A round

15:40 EDT 25 May 2018 | Elsevier Business Intelligence

Atomwise Inc. (AI using deep neural networks for drug discovery) closed a $45mm Series A round co-led by Monsanto Growth Vent...

Original Article: AI firm Atomwise secures $45mm Series A round

NEXT ARTICLE

More From BioPortfolio on "AI firm Atomwise secures $45mm Series A round"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...